Predicting T-cell receptor (TCR)–peptide-MHC (pMHC) binding is central to vaccine design and T-cell therapy, yet deployed models frequently encounter epitopes unseen during training, causing silent overconfidence and unreliable prioritization. We address this by framing TCR–pMHC prediction as a \emph{selective prediction} problem: a calibrated model should either output a trustworthy confidence score or explicitly abstain. Concretely, we (1) introduce a dual-encoder architecture encoding both CDR3/CDR3 and peptide sequences via a pre-trained protein language model; (2) apply temperature scaling to correct systematic probability miscalibration; and (3) impose a conformal abstention rule that provides finite-sample coverage guarantees at a user-specified target error rate. Evaluated under three split strategies – random, epitope-held-out, and distance-aware – our method achieves AUROC 0.813 and ECE 0.043 under the challenging epitope-held-out protocol, reducing ECE by 69.7% relative to an uncalibrated baseline. At 80% coverage, the selective model further reduces error rate from 18.7% to 10.9%, demonstrating that calibrated abstention enables principled coverage-risk trade-offs aligned with practical screening budgets.

生成讲解博客的中文版本

生成AI智能校验的中文版本